Peter Krantz is our Chief Executive Officer of Multipharma SA and its affiliates. He completed his studies at the Federal Institute of Technology in Zurich, Switzerland with a Master’s of Science and Master’s of Business Administration and spent several years working for a U.S. Multinational Company. Since 1993, he has been extensively involved in all aspects of the Pharmaceutical Business. He is a Swiss citizen and is fluent in English, German, French, Italian and Swedish.

Lekishia White is our Managing Director of Multipharma, Inc. and manages the United States operations with additional emphasis on the Canadian and South American markets. She obtained her Bachelor of Science degree in Biology from Spelman College and her Master’s of Business Administration degree from Pepperdine University. She has over six years of experience in laboratory research and development, and for ten years, she worked in many capacities and in several departments for Amgen, Inc. She has expertise and proficiency in areas of GMP operations, warehousing and logistics, quality and regulatory compliance, supply chain management and strategic sourcing. She is a U.S. citizen.

After graduating from the National Taiwan University in International Business, Kay-Christian led the business unit Oncology and Specialised Therapeutics of Schering AG (Germany) in Taiwan. This company is now part of Bayer Healthcare Pharmaceuticals. During this assignment he and his team were responsible for sales and marketing of several scientifically challenging products and deeply involved with Named Patient as well as Pre-Marketing programs. He then moved on to establish new areas of activity in his capacity as Regional Business Development Manager. He was mainly engaged in the planning and execution of clinical trials and the logistics of IMPs. Since 2009 Kay-Christian has been establishing the activities of the Multipharma Group in the EU, particularly Germany, as well as in Asia. Apart from the supply of global clinical trials his focus lies with the expansion of international activities in the areas of sales, marketing and distribution of specialised products.

Akiko Sunahara is our Managing Director of Multipharma, Ltd. and manages the Japanese clinical trial supply operations. She received her Bachelor of Science degree in the Department of Agricultural Chemistry from Kyoto University Japan and acquired her Master’s of Agricultural Science degree from the Graduate School of Kyoto University. After graduation, she joined Daiichi Sankyo and engaged in conducting CT and business improvement projects. She is a Japanese citizen.

After graduating from the University of Edinburgh with a BSc (Hons) in Biological Sciences (Pharmacology), Ann-Marie Huss moved to Germany. She began working at a Berlin-based contract research organisation, primarily focusing on phase I clinical trials, where she worked within the project and quality management teams. Upon joining Multipharma, she was initially involved in implementation of the company’s internal data management system as well as assisting on several key comparator sourcing projects.  Later she was appointed Project Manager, co-ordinating pre-marketing and named-patient programs within Germany.  In her new role as managing director, she is focusing on the establishment of Multipharma’s clinical trial supply services within the UK as well as continuing her involvement in the company’s pre-marketing and named-patient programs.